2 terminated, 1 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow BK Virus Infection: new trials by email Literature Review of BK Virus Infection trials Research Report on BK Virus Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant Posoleucel (ALVR105), Placebo - Adenovirus Infection, BK Virus Infection | Phase 2 / Phase 3 | Terminated | AlloVir | 451 | 2022-03-24 | 2024-05-16 |
| Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) Posoleucel (ALVR105), Placebo - BK Virus Infection, Hemorrhagic Cystitis | Phase 3 | Terminated | AlloVir | 97 | 2021-03-18 | 2024-05-14 |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant Posoleucel (ALVR105) - Adenovirus Infection, BK Virus Infection | Phase 2 / Phase 3 | Completed | AlloVir | 26 | 2021-01-15 | 2024-05-09 |
Adenoviridae Infections (2) · Cytomegalovirus Infections (2) · Epstein-Barr Virus Infections (2) · Cystitis, Hemorrhagic (1)
DNA Virus Infections (2) · Herpesviridae Infections (2) · Infections (2) · Tumor Virus Infections (2) · Virus Diseases (2) · Cystitis (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Urinary Bladder Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
AlloVir (3)
United States (3) · France (2) · Italy (2) · South Korea (2) · Spain (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Canada (1) · Sweden (1) · Turkey (Türkiye) (1)